MyFinsight
Home
Blog
About
Back
Income Statement
Kura Oncology, Inc. (KURA)
Kura Oncology, Inc. (KURA)
source: myfinsight.com
Comprehensive loss
-$69,160K
Net loss
-$68,327K
(-3.33%↓ Y/Y)
Unrealized loss on
short-term investments
-$833K
Interest and other
income, net
$5,033K
(-27.43%↓ Y/Y)
Loss before income
taxes
-$68,322K
(-3.33%↓ Y/Y)
Income tax expense
$5K
Total other income,
net
$4,688K
(-28.36%↓ Y/Y)
License And
Collaboration Revenue
$11,752K
Product
$9,122K
Interest expense
$345K
(-11.76%↓ Y/Y)
Loss from operations
-$73,010K
(-0.47%↓ Y/Y)
Total revenue
$20,874K
(36.54%↑ Y/Y)
Total operating
expenses
$93,884K
(6.74%↑ Y/Y)
Research and development
$61,891K
(-1.42%↓ Y/Y)
Selling, general and
administrative
$31,750K
Cost of product sales
$243K
Back